Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 501 to 550 of 8289 in total 
Value Type: Measured
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
251\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
kynureninase (ec 3.7.1.3) (l-kynurenine hydrolase). [source:swissprot;acc:q16719]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8527.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9058.09\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06221\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tyrosine-protein kinase hck (ec 2.7.1.112) (p59-hck/p60-hck) (hemopoietic cell kinase). [source:swissprot;acc:p08631]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6417.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7859.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22477\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
252\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
1-acyl-sn-glycerol-3-phosphate acyltransferase gamma (ec 2.3.1.51) (1- agp acyltransferase 3) (1-agpat 3) (lysophosphatidic acid acyltransferase-gamma) (lpaat-gamma) (1-acylglycerol-3-phosphate o- acyltransferase 3). [source:swissprot;acc:q9nrz7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8492.92\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9018.94\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06194\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
crk-like protein. [source:swissprot;acc:p46109]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6417.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7859.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22477\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
253\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
fructose-1,6-bisphosphatase isozyme 2 (ec 3.1.3.11) (d-fructose-1,6- bisphosphate 1-phosphohydrolase) (fbpase). [source:swissprot;acc:o00757]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8223.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8732.25\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06188\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase abl1 (ec 2.7.1.112) (p150) (c-abl). [source:swissprot;acc:p00519]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6417.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7859.59\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22477\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
254\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dj842g6.2 (novel protein imilar to sel1l (sel-1 (suppressor of lin-12, c.elegans)-like)) (fragment). [source:sptrembl;acc:q9ugd3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8219.97\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8727.87\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06179\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase fyn (ec 2.7.1.112) (p59-fyn) (syn) (slk). [source:swissprot;acc:p06241]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6417.18\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
7859.6\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.22477\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
255\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase fgr (ec 2.7.1.112) (p55-fgr) (c-fgr). [source:swissprot;acc:p09769]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sel-1 homolog precursor (suppressor of lin-12-like protein) (sel-1l). [source:swissprot;acc:q9ubv2]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8219.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8727.84\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06179\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
256\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
fructose-1,6-bisphosphatase (ec 3.1.3.11) (d-fructose-1,6-bisphosphate 1-phosphohydrolase) (fbpase). [source:swissprot;acc:p09467]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8216.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8723.91\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06171\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
grb2-related adaptor protein 2 (gads protein) (growth factor receptor binding protein) (grblg) (grf40 adaptor protein) (grf-40) (grb-2-like protein) (grb2l) (grbx) (p38) (hematopoietic cell-associated adaptor protein grpl) (adapter protein grid) (sh3-sh2-sh3 adaptor mona). [source:swissprot;acc:o75791]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6417.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7859.51\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22476\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
257\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ccaat displacement protein (cdp) (cut-like 1). [source:swissprot;acc:p39880]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6417.31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7858.12\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22452\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
synaptojanin 1 (ec 3.1.3.36) (synaptic inositol-1,4,5-trisphosphate 5- phosphatase 1). [source:swissprot;acc:o43426]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8082.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8579.93\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06157\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
258\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
aflatoxin b1 aldehyde reductase 2 (ec 1.-.-.-) (afb1-ar 2). [source:swissprot;acc:o95154]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
9249.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9818.95\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06154\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein cux-2 (cut-like 2) (fragment). [source:swissprot;acc:o14529]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6417.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7857.93\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22449\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
259\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
neural wiskott-aldrich syndrome protein (n-wasp). [source:swissprot;acc:o00401]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6417.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7852.52\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22355\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
oligophrenin 1. [source:swissprot;acc:o60890]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6428.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6824.22\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06152\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
260\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
aflatoxin b1 aldehyde reductase 1 (ec 1.-.-.-) (afb1-ar 1) (aldoketoreductase 7). [source:swissprot;acc:o43488]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
9246.23\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9814.59\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06147\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
signal recognition particle 9 kda protein (srp9). [source:swissprot;acc:p49458]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4244.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5193.42\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22343\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
261\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adrenodoxin, mitochondrial precursor (adrenal ferredoxin) (hepatoredoxin) (ferredoxin 1). [source:swissprot;acc:p10109]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8837.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9379.17\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06133\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
signal recognition particle 9 kda protein (srp9). [source:swissprot;acc:p49458]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
4247.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5192.61\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22255\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
262\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cleavage and polyadenylation specific factor 4, 30kd subunit; cleavage-polyadenylation specificity factor, 30kd; no arches-like (zebrafish) zinc finger protein; cleavage-polyadenylation specificity factor. [source:refseq;acc:nm\_006693]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
24896.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
20431.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.21852\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
oligophrenin-1 like protein (gtpase regulator associated with focal adhesion kinase). [source:swissprot;acc:q9una1]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6440.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6834.37\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06122\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
263\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
oligosaccharyl transferase stt3 subunit homolog (b5) (integral membrane protein 1) (tmc). [source:swissprot;acc:p46977]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7424.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7877.49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06106\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
trs85 homolog. [source:swissprot;acc:q9y2l5]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
24896.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
20431.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.21852\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
264\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cop9 constitutive photomorphogenic homolog subunit 3; cop9 complex subunit 3; jab1-containing signalosome subunit 3. [source:refseq;acc:nm\_003653]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
4987.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4094.57\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.2181\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
diacylglycerol kinase, theta (ec 2.7.1.107) (diglyceride kinase) (dgk- theta) (dag kinase theta). [source:swissprot;acc:p52824]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6396.44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6786.96\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06105\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
265\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
synaptojanin 2 (ec 3.1.3.36) (synaptic inositol-1,4,5-trisphosphate 5- phosphatase 2) (fragment). [source:swissprot;acc:o15056]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8081.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8573.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06098\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
wd-repeat protein wdc146. [source:swissprot;acc:q9c0j8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
24806.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
20369.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.21782\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
266\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
carboxypeptidase a1 precursor (ec 3.4.17.1). [source:swissprot;acc:p15085]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8817.03\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9353.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06089\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
cleavage and polyadenylation specificity factor, 160 kda subunit (cpsf 160 kda subunit). [source:swissprot;acc:q10570]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
24806.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
20369.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.21782\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
267\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
choline/ethanolaminephosphotransferase. [source:refseq;acc:nm\_006090]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8813.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9348.71\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06069\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ral guanine nucleotide dissociation stimulator (ralgef) (ralgds). [source:swissprot;acc:q12967]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
14021.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11523\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.21682\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
268\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cleavage and polyadenylation specificity factor, 100 kda subunit (cpsf 100 kda subunit) (fragment). [source:swissprot;acc:q9p2i0]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
24473.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
20127.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.21593\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
reversion-inducing cysteine-rich protein with kazal motifs precursor (hreck) (suppressor of tumorigenicity 15) (st15). [source:swissprot;acc:o95980]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8813.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9348.71\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.06069\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
269\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
choline phosphotransferase 1; cholinephosphotransferase 1 alpha; cholinephosphotransferase 1. [source:refseq;acc:nm\_020244]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8813.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9348.9\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
u6 snrna-associated sm-like protein lsm8. [source:swissprot;acc:o95777]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4590.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5575.52\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.21466\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
270\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
carboxypeptidase a5. [source:refseq;acc:nm\_080385]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8811.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9345.51\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06056\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
fip1-like 1; rearranged in hypereosinophilia. [source:refseq;acc:nm\_030917]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
23640.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
19479.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.21358\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
271\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
carboxypeptidase b precursor (ec 3.4.17.2) (pancreas-specific protein) (pasp). [source:swissprot;acc:p15086]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8811.69\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9345.26\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06055\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
chromatin accessibility complex protein 1 (chrac-1) (chrac-15) (huchrac15) (dna polymerase epsilon subunit p15). [source:swissprot;acc:q9nrg0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2554.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3093.78\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.21092\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
272\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial precursor (ec 1.5.1.12) (p5c dehydrogenase). [source:swissprot;acc:p30038]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11162\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10526.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0604\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
histone acetyltransferase type b catalytic subunit (ec 2.3.1.48). [source:swissprot;acc:o14929]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
3858.52\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4669.27\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.21012\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
273\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 5 (eif-5). [source:swissprot;acc:p55010]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
3199.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3870.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20985\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
phospholipase a-2-activating protein (plap) (pla2p). [source:swissprot;acc:q9y263]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11162\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10526.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0604\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
274\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromosome 3p21.1 gene sequence. [source:refseq;acc:nm\_013286]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3119.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2579.49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20953\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
small nuclear ribonucleoprotein f (snrnp-f) (sm protein f) (sm-f) (smf). [source:swissprot;acc:q15356]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7718.85\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8184.75\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06036\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
275\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
regulator of g-protein signaling 19 (rgs19) (g-alpha interacting protein) (gaip protein). [source:swissprot;acc:p49795]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3119.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2579.49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20953\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
udp-glucose 4-epimerase (ec 5.1.3.2) (galactowaldenase) (udp- galactose 4-epimerase). [source:swissprot;acc:q14376]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7506.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7958.12\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06021\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/